MRPL13 and non-small cell lung carcinoma: Studies have shown that inhibiting MRPL13 can slow down the proliferation of breast cancer cells and EMT process, while reducing the resistance of non-small cell lung cancer cells to anthracyclines chemotherapy drugs.